Clover Health Investments, Corp. (NASDAQ:CLOV): favorable market dynamics and the recent correction in share prices call for investigation of an opportunity to gain exposure to the Medicare Advantage market. Still, after examining the current
Investors Unlikely To See Sharp Rebound In Clover Health Shares
Summary
- Clover Health operates in an expanding market, and the recent correction in share price warrants an investigation of a possible opportunity to gain exposure to the Medicare Advantage market.
- After closer examination, the share price seems fully valued, considering historical growth rate and peer comparisons.
- The much-promoted Clover Assistant software doesn't create enough moat to justify a valuation premium above peers.
Bashar is a contributing writer at Seeking Alpha, focusing on Long/Short investment ideas, with a geographic focus in North America. Before that, Bashar worked at an Investment Fund in the United Kingdom. He has a Master's degree in Finance from the Queen Mary University of London and a Bachelor's degree in Economics from Middlesex University.
Analyst’s Disclosure:I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.